The Clinical Impact of Hepatic Arterial Infusion Chemotherapy New-FP for Hepatocellular Carcinoma with Preserved Liver Function.
Hideki IwamotoTakashi NiizekiHiroaki NagamatsuKazuomi UeshimaJoji TaniTeiji KuzuyaKazuhiro KasaiYouhei KookaAtsushi HiraokaRie SugimotoTakehiro YonezawaSatoshi TanakaAkihiro DeguchiShigeo ShimoseTomotake ShironoMiwa SakaiHiroyuki SuzukiEtsuko MoriyamaHironori KogaTakuji TorimuraTakumi Kawaguchinull New Fp Study Groupnull Kurume Liver Cancer Study Group Of JapanPublished in: Cancers (2022)
HAIC using New-FP is promising for patients with MVI- and major PVTT-HCC in preserved liver function.
Keyphrases